3CMH - Header Asymmetric Unit

HEADER CONTRACTILE PROTEIN 03-SEP-98 3CMH

TITLE SYNTHETIC LINEAR TRUNCATED ENDOTHELIN-1 AGONIST

COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (ENDOTHELIN-1); COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: TRUNCATED ET-1 ANALOGUE AIB AT POSITION 11

SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED FROM SOURCE 4 A BIOLOGICAL SOURCE.

KEYWDS VASOCONSTRICTOR, ENDOTHELIN-1, CONTRACTILE PROTEIN

EXPDTA SOLUTION NMR

AUTHOR C.M.HEWAGE,L.JIANG,J.A.PARKINSON,R.RAMAGE,I.H.SADLER

REVDAT 2 24-FEB-09 3CMH 1 VERSN REVDAT 1 29-SEP-99 3CMH 0

JRNL AUTH C.M.HEWAGE,L.JIANG,J.A.PARKINSON,R.RAMAGE, JRNL AUTH 2 I.H.SADLER JRNL TITL SOLUTION STRUCTURE OF A NOVEL ETB RECEPTOR JRNL TITL 2 SELECTIVE AGONIST ET1-21 [CYS(ACM)1,15, AIB3,11, JRNL TITL 3 LEU7] BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY JRNL TITL 4 AND MOLECULAR MODELLING. JRNL REF J.PEPT.RES. V. 53 223 1999 JRNL REFN ISSN 1397-002X JRNL PMID 10231710 JRNL DOI 10.1034/J.1399-3011.1999.00001.X

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TRIPOS 6.1 REMARK 3 AUTHORS : JONES,ZOU,COWAN,KJELDGAARD REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 3CMH COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-JUL-99. REMARK 100 THE RCSB ID CODE IS RCSB007006.

REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 3.6 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : 50% H2O/ 50% CD3OH REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NOESY, TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : SYBYL TRIPOS REMARK 210 METHOD USED : DG, DSA, MD REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 10 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: 2D NMR METHODS USED

REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TRP A 21 CE2 - CD2 - CG ANGL. DEV. = -4.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 8 -75.54 -168.14 REMARK 500 REMARK 500 REMARK: NULL

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6CMH RELATED DB: PDB

DBREF 3CMH A 7 21 UNP P22388 EDN1_RAT 59 73

SEQADV 3CMH LEU A 7 UNP P22388 MET 59 CONFLICT SEQADV 3CMH AIB A 11 UNP P22388 CYS 63 CONFLICT

SEQRES 1 A 15 LEU ASP LYS GLU AIB VAL TYR PHE CYS HIS LEU ASP ILE SEQRES 2 A 15 ILE TRP

MODRES 3CMH AIB A 11 ALA ALPHA-AMINOISOBUTYRIC ACID

HET AIB A 11 13

HETNAM AIB ALPHA-AMINOISOBUTYRIC ACID

FORMUL 1 AIB C4 H9 N O2

HELIX 1 1 LYS A 9 LEU A 17 5 9

LINK C GLU A 10 N AIB A 11 1555 1555 1.35 LINK C AIB A 11 N VAL A 12 1555 1555 1.35

CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 1.000000 0.000000 0.000000 0.00000

SCALE2 0.000000 1.000000 0.000000 0.00000

SCALE3 0.000000 0.000000 1.000000 0.00000